Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients.

Kicman, Aleksandra; Niczyporuk, Marek; Kulesza, Monika; Motyka, Joanna; Lawicki, Slawomir

Kicman, Aleksandra; Niczyporuk, Marek; Kulesza, Monika; Motyka, Joanna; Lawicki, Slawomir.

Affiliation

Kicman A; Department of Aesthetic Medicine, Medical University of Bialystok, Bialystok, Poland.
Niczyporuk M; Department of Aesthetic Medicine, Medical University of Bialystok, Bialystok, Poland.
Kulesza M; Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Bialystok, Poland.
Motyka J; Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Bialystok, Poland.
Lawicki S; Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Bialystok, Poland.

Cancer Manag Res ; 14: 3359-3382, 2022.

Article de En | MEDLINE | ID: mdl-36474934

Mots clés

carcinogenesis; extracellular matrix metalloproteinases; ovarian cancer; tumor markers

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Cancer Manag Res Année: 2022 Type de document: Article Pays d'affiliation: Pologne Pays de publication: Nouvelle-Zélande

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google